News Alert: GE Healthcare recalls certain SpO2 sensors due to risk of errors during defibrillation | Cardiovascular Business

Home

Recent Newsletters

FDA confirms recall after device left in patient’s body | Bleeding reversal agent pulled from market | ACC & AHA take on PAD

Key trends in cardiovascular health | FDA approves PFA catheter | Bayer makes a move | Medtech company acquired | CCTA education

CCTA making an impact | Cardiology's biggest trend | Recall confirmed | Philips, Bayer announce new deals | Positron raises $2M

‘Mental clarity’ supplement recalled | New data on SDD after PCI | FDA clears diabetes tech | Stroke on plane leads to lawsuit

FDA approves nasal spray for abnormal heart rhythms | Abbott's big news | CBD shows potential | AI powers new PFA registry

JenaValve acquisition blocked | Cath labs keeping up with changes | A new PAD resource | Supplement recalled | RSNA seeks editor

Week in Review: Trump's heart health | FDA announces multiple recalls | Positron raises $2M | IVL's future | CBD & heart disease

Design by Adaptive Theme